. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Delivery of Biologically Active Antibodies into Human Cells by a Non-Covalently Attached Naturally Occurring Peptide Moiety

Reference #:

2006-123

Inventors/Contributors

Gobinda Sarkar, Ph.D., Mark E. Bolander, M.D., Deendayal Mandal, Ph.D., Eric W. Mahlum

Description

Novel peptides have been designed to noncovalently bind proteins or nucleic acids and transport them into nucleus, through both the cellular and nuclear membranes. Transported proteins include IgG, beta-galactosidase, and GFP. Transported nucleic acids include single stranded oligonucleotides and plasmid DNA. These peptides and methodologies suggest an ability to treat diseases with protein or nucleic acid modulation.

Patent Status

Pending

Contact

Manu Nair, Licensing Manager
nair.manu@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Intellectual Property
MN BioBusiness Center
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-0558
Fax: (507) 284-5410